On November 7, the award ceremony of the annual competition of pharmaceutical industry professionals “Panacea 2023” took place. At it, the Farmak company received an award in the “Company of the Year” nomination. Domestic manufacturer.”
The ranking of the winners in the nomination was compiled according to data from the analytical companies Business Credit, SMD and IQVIA for the period – III, IV quarters of 2022; I, II quarters of 2023.
Farmak also received the honorary “FarmFront” commemorative distinction, made from the debris of the Kynzhal ballistic missile shot down over Kyiv. “Panacea” noted that the company, despite difficult times, continues to invest in development in Ukraine. In 2022, the amount of investment amounted to about UAH 1 billion, these funds were used to open new production sites and modernize existing ones, as well as research and launch new medicines on the market.
Since the beginning of the full-scale invasion, the company not only has not reduced staff, but has already raised workers’ wages twice, provided them with safe working conditions and modernized the shelter.
In addition, Farmak is the largest taxpayer among Ukrainian drug manufacturers, for the first half of 2023, the company paid UAH 400 million to the state treasury. The company has been supporting the Ukrainian army since 2014, and from the beginning of the full-scale invasion to September 2023, the Zhebrivsky Family Charitable Foundation* provided assistance worth UAH 100 million to our defenders.
* The Zhebrivsky Family Charitable Foundation and the Farmak company are part of the activities of the Zhebrivsky family and carry out the family’s charitable and business activities.
